Tenet ( THC) investors, anxious over the outcome of a high-profile criminal trial, continue their agonizing stay in the waiting room. Despite recent complaints from a juror that sparked the prospect of a mistrial, a 3-year-old kickback case involving the hospital chain continues to drag on. A San Diego jury now faces its 39th day of deliberations in an extraordinarily long 10-month trial that follows an earlier mistrial last year. Prudential analyst David Shove had clearly hoped for better when hearing about some possible jury turmoil last week. "We have always believed that the longer this jury deliberates, the greater the chance of no verdict," wrote Shove, who has a neutral-weight rating and a $9 price target on Tenet's stock. "We also believe that if this trial ends in a hung jury, there will not be a third trial. All of this would be especially positive for Tenet, as they would be able to start recruiting doctors more aggressively and volumes at the company may improve. Maybe -- just maybe -- it is getting closer to this outcome." For now, however, a federal judge has paved the way for deliberations to continue by denying Tenet's latest efforts to have the case dismissed. In addition, the San Diego Union-Tribune reported on Wednesday, the judge has decided against unsealing some documents -- including a sensitive juror note -- that could have shed some light on the jury's debate over whether the defendants engaged in illegal behavior. A Tenet subsidiary, the company's Alvarado Hospital Medical Center in San Diego and former Alvarado CEO Barry Weinbaum, stand accused of giving doctors illegal kickbacks in exchange for patient referrals. The defendants have claimed that they offered the doctors legitimate "relocation packages" to address physician shortages instead. The case has reportedly dampened enthusiasm for relocation packages throughout the hospital industry. But it has taken an especially heavy toll on Tenet, which has seen its relationships with physicians strained -- and its patient volumes hurt -- in the wake of intense government scrutiny.